Update on protracted bacterial bronchitis in children

Xiao-Bo Zhang1, Xiao Wu1, Guang-Min Nong2

  • 1Pediatric Department, First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.

Insights

Protracted bacterial bronchitis (PBB) in children often presents as chronic wet cough, particularly in young males, and may involve wheezing and airway issues. Treatment is effective for most, but prolonged antibiotics may be needed for those with comorbidities.

Area of Science:

  • Pediatrics
  • Respiratory Medicine
  • Infectious Diseases

Background:

  • Chronic cough is a prevalent symptom in pediatric populations.
  • Protracted bacterial bronchitis (PBB) is a significant, yet not fully understood, cause of chronic cough in children.
  • This study aims to provide an updated understanding of PBB in children.

Purpose of the Study:

  • To update current knowledge on protracted bacterial bronchitis (PBB) in children.
  • To analyze clinical features and outcomes of PBB in pediatric patients.
  • To compare PBB characteristics between China and Western countries.

Main Methods:

  • Retrospective analysis of clinical data from 712 children diagnosed with PBB (2014-2018).
  • Inclusion of 52 cases from the authors' center and 660 cases from 14 published studies.
  • Systematic literature review of electronic databases (May 2019) for relevant clinical studies.

Main Results:

  • PBB predominantly affects children under 6 years, presenting with chronic wet cough.
  • Laryngomalacia was identified in 3 cases; microbiologically confirmed PBB involved Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa.
  • Most patients experienced symptom resolution after treatment, though comorbidities necessitated prolonged antibiotic courses.

Conclusions:

  • Protracted bacterial bronchitis (PBB) is common in male infants with chronic wet cough, often accompanied by wheezing and airway deformities.
  • Clinical diagnosis of PBB is prevalent in China, while microbiologically confirmed cases are more common in Western countries.
  • Streptococcus pneumoniae and Haemophilus influenza are key pathogens; extended antibiotic treatment may be required for patients with comorbidities.
Abstract

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.8K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.1K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
751
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
654